Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Ex vivo model of human skin (hOSEC) for assessing the dermatokinetics of the anti-melanoma drug Dacarbazine

Texto completo
Autor(es):
Leite, Marcel Nani [1] ; Rosa Viegas, Juliana Santos [2] ; Garcia Praca, Fabiola Silva [2] ; de Paula, Natalia Aparecida [1] ; Zambelli Ramalho, Leandra Naira [3] ; Lopes Badra Bentley, Maria Vitoria [2] ; Cipriani Frade, Marco Andrey [1]
Número total de Autores: 7
Afiliação do(s) autor(es):
[1] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Internal Med, Div Dermatol, Wound Healing & Hansens Dis Lab, Ribeirao Preto, SP - Brazil
[2] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Ribeirao Preto, SP - Brazil
[3] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pathol & Legal Med, Ribeirao Preto, SP - Brazil
Número total de Afiliações: 3
Tipo de documento: Artigo Científico
Fonte: European Journal of Pharmaceutical Sciences; v. 160, MAY 1 2021.
Citações Web of Science: 0
Resumo

Alternative models to replace animals in experimental studies remain a challenge in testing the effectiveness of dermatologic and cosmetic drugs. We proposed a model of human organotypic skin explant culture (hOSEC) to assess the profile of cutaneous drug skin distribution, adopting dacarbazine as a model, and respective new methodologies for dermatokinetic analysis. The viability tests were evaluated in primary keratinocytes and fi-broblasts, and skin by MTT and TTC assays, respectively. Then, dacarbazine was applied to the culture medium, and the hOSEC method was applied to verify the dynamics of skin distribution of dacarbazine and determine its dermatokinetic profile. The results of cell and tissue viability showed that both were considered viable. The dermatokinetic results indicated that dacarbazine can be absorbed through the skin, reaching a concentration of 36.36 ?g/mL (18,18%) of the initial dose (200 ?g/mL) after 12 h in culture. Histological data showed that the skin maintained its structure throughout the tested time that the hOSEC method was applied. No apoptotic cells were observed in the epidermal and dermal layers. No visible changes in the dermo-epidermal junction and no inflammatory processes with the recruitment of defense cells were observed. Hence, these findings suggest that the hOSEC concept as an alternative ex vivo model for assessing the dynamics of skin distribution of drugs, such as dacarbazine, and determining their respective dermatokinetic profiles. (AU)

Processo FAPESP: 16/16437-7 - Avaliação da viabilidade do modelo de pele humana ex vivo (hOSEC) e sua aplicação em estudos de eficácia de protetores solares a longo prazo no fotoenvelhecimento
Beneficiário:Marco Andrey Cipriani Frade
Modalidade de apoio: Auxílio à Pesquisa - Regular
Processo FAPESP: 14/50928-2 - INCT 2014: Nanotecnologia Farmacêutica: uma abordagem transdisciplinar
Beneficiário:Maria Vitória Lopes Badra Bentley
Modalidade de apoio: Auxílio à Pesquisa - Temático
Processo FAPESP: 19/04448-2 - Desenvolvimento de carreador lipídico nanoestruturado contendo pool de siRNAs associados à agente antitumoral como uma abordagem terapêutica multifuncional para o Câncer de pele
Beneficiário:Juliana dos Santos Rosa
Modalidade de apoio: Bolsas no Brasil - Doutorado